• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险优势计划和退伍军人事务医疗保健系统中双重参保者的冠状动脉血运重建术的联邦支付。

Federal Payments for Coronary Revascularization Procedures Among Dual Enrollees in Medicare Advantage and the Veterans Affairs Health Care System.

机构信息

Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.

Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania, Philadelphia.

出版信息

JAMA Netw Open. 2020 Apr 1;3(4):e201451. doi: 10.1001/jamanetworkopen.2020.1451.

DOI:10.1001/jamanetworkopen.2020.1451
PMID:32250432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7136831/
Abstract

IMPORTANCE

More than 1 million US veterans are dually enrolled in a Medicare Advantage (MA) plan and in the Veterans Affairs (VA) health care system. The federal government prepays private MA plans to cover veterans; if a dually enrolled veteran receives an MA-covered service at the VA, the government is making 2 payments for the same service. It is not clear what proportion of veterans dually enrolled in VA and MA are undergoing coronary revascularization at VA vs non-VA hospitals.

OBJECTIVE

To describe where veterans who are enrolled in both VA and MA undergo coronary revascularization and the associated costs.

DESIGN, SETTINGS, AND PARTICIPANTS: This is a cohort study consisting of US veterans dually enrolled in VA and MA from January 1, 2010, to December 31, 2013, who had at least 1 VA encounter and underwent coronary revascularization during the study period. Data were analyzed from April 2019 to September 2019.

MAIN OUTCOMES AND MEASURES

Number of coronary artery bypass graft (CABG) operations and percutaneous coronary interventions (PCIs) performed through the VA and through MA during years 2010 to 2013, and the associated VA costs of coronary revascularization. In addition, multivariable logistic regression was performed to assess patient factors associated with receiving care through the VA.

RESULTS

A total of 18 874 VA users with concurrent MA enrollment who underwent coronary revascularization during 2010 to 2013 were identified (mean [SD] age, 75.3 [8.8] years; 18 739 men [99.0%]). Enrollees were predominantly white (17 457 patients [92.0%]). Among patients, 4115 (22.0%) underwent either CABG or PCI through the VA only, 14 281 (75.0%) did so through MA only, and 478 (2.5%) underwent coronary revascularization procedures through both payers. From 2010 to 2013, these veterans underwent 4764 coronary revascularization procedures (721 CABGs and 3043 PCIs) that cost the VA $214.7 million ($115.8 million for CABGs and $99.0 million for PCIs). In multivariable analysis, nonwhite patients were more likely than white patients to undergo coronary revascularization through the VA (odds ratio, 1.73; 95% CI, 1.52-1.96; P < .001), and for each year of age, veterans were less likely to undergo coronary revascularization through the VA (odds ratio, 0.95; 95% CI, 0.94-0.95; P < .001). There was no statistically significant association between undergoing coronary vascularization through the VA and distance in miles to the nearest VA hospital (odds ratio, 1.00; 95% CI, 0.99-1.00; P = .30).

CONCLUSIONS AND RELEVANCE

A substantial share of VA users concurrently enrolled in an MA plan underwent coronary revascularization procedures through the VA, incurring significant duplicative federal health care spending. Given the financial pressures facing both Medicare and the VA, government officials should consider policy solutions to mitigate redundant spending.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8571/7136831/d7bc5dc09078/jamanetwopen-3-e201451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8571/7136831/b47ec2ffbc59/jamanetwopen-3-e201451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8571/7136831/d7bc5dc09078/jamanetwopen-3-e201451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8571/7136831/b47ec2ffbc59/jamanetwopen-3-e201451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8571/7136831/d7bc5dc09078/jamanetwopen-3-e201451-g002.jpg
摘要

重要性

超过 100 万美国退伍军人同时参加了医疗保险优势(MA)计划和退伍军人事务部(VA)的医疗保健系统。联邦政府预付私人 MA 计划以支付退伍军人的费用;如果同时参加 VA 和 MA 的退伍军人在 VA 接受 MA 覆盖的服务,政府将为同一服务支付两次费用。目前尚不清楚在 VA 医院和非 VA 医院接受冠状动脉血运重建的同时参加 VA 和 MA 的退伍军人中,有多少人属于这种情况。

目的

描述同时参加 VA 和 MA 的退伍军人进行冠状动脉血运重建的情况以及相关费用。

设计、地点和参与者:这是一项队列研究,纳入了 2010 年 1 月 1 日至 2013 年 12 月 31 日期间同时参加 VA 和 MA 的美国退伍军人,他们至少有一次 VA 就诊,并在研究期间进行了冠状动脉血运重建。数据分析于 2019 年 4 月至 2019 年 9 月进行。

主要结果和测量指标

2010 年至 2013 年期间,VA 和 MA 进行的冠状动脉旁路移植术(CABG)和经皮冠状动脉介入术(PCI)的数量,以及与冠状动脉血运重建相关的 VA 费用。此外,还进行了多变量逻辑回归分析,以评估与通过 VA 接受治疗相关的患者因素。

结果

共确定了 2010 年至 2013 年期间同时参加 MA 计划的 18874 名接受冠状动脉血运重建的 VA 用户(平均[SD]年龄,75.3[8.8]岁;18739 名男性[99.0%])。患者主要为白人(17457 名患者[92.0%])。在患者中,4115 名(22.0%)仅通过 VA 进行了 CABG 或 PCI,14281 名(75.0%)仅通过 MA 进行了 CABG 或 PCI,478 名(2.5%)通过两个支付者进行了冠状动脉血运重建手术。从 2010 年到 2013 年,这些退伍军人进行了 4764 次冠状动脉血运重建手术(721 例 CABG 和 3043 例 PCI),这使 VA 花费了 2.147 亿美元(1.158 亿美元用于 CABG 和 9900 万美元用于 PCI)。在多变量分析中,非白人患者比白人患者更有可能通过 VA 进行冠状动脉血运重建(优势比,1.73;95%CI,1.52-1.96;P<0.001),并且随着年龄的增长,退伍军人通过 VA 进行冠状动脉血运重建的可能性降低(优势比,0.95;95%CI,0.94-0.95;P<0.001)。通过 VA 进行冠状动脉血运重建与距离最近的 VA 医院的英里数之间没有统计学意义上的关联(优势比,1.00;95%CI,0.99-1.00;P=0.30)。

结论和相关性

同时参加 MA 计划的 VA 用户中,相当一部分人通过 VA 进行了冠状动脉血运重建手术,这导致了大量重复的联邦医疗保健支出。鉴于医疗保险和 VA 都面临着财政压力,政府官员应该考虑制定政策解决方案来减轻冗余支出。

相似文献

1
Federal Payments for Coronary Revascularization Procedures Among Dual Enrollees in Medicare Advantage and the Veterans Affairs Health Care System.医疗保险优势计划和退伍军人事务医疗保健系统中双重参保者的冠状动脉血运重建术的联邦支付。
JAMA Netw Open. 2020 Apr 1;3(4):e201451. doi: 10.1001/jamanetworkopen.2020.1451.
2
Comparison of Accessibility, Cost, and Quality of Elective Coronary Revascularization Between Veterans Affairs and Community Care Hospitals.退伍军人事务部和社区护理医院选择性冠状动脉血运重建的可及性、成本和质量比较。
JAMA Cardiol. 2018 Feb 1;3(2):133-141. doi: 10.1001/jamacardio.2017.4843.
3
Duplicate federal payments for dual enrollees in Medicare Advantage plans and the Veterans Affairs health care system.医疗保险优势计划和退伍军人事务医疗保健系统中双重参保人的重复联邦支付。
JAMA. 2012 Jul 4;308(1):67-72. doi: 10.1001/jama.2012.7115.
4
Increasing use of Medicare services by veterans with acute myocardial infarction.急性心肌梗死退伍军人对医疗保险服务的使用增加。
Med Care. 1999 Jun;37(6):529-37. doi: 10.1097/00005650-199906000-00002.
5
Mortality of Department of Veterans Affairs patients undergoing coronary revascularization in private sector hospitals.在私立医院接受冠状动脉血运重建术的退伍军人事务部患者的死亡率。
Health Serv Res. 2007 Oct;42(5):1802-21. doi: 10.1111/j.1475-6773.2007.00720.x.
6
Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015.2013 年至 2015 年美国退伍军人事务部医院中稳定型冠心病患者经皮冠状动脉介入治疗的适宜性。
JAMA Netw Open. 2020 Apr 1;3(4):e203144. doi: 10.1001/jamanetworkopen.2020.3144.
7
Veterans Health Administration patients' use of the private sector for coronary revascularization in New York: opportunities to improve outcomes by directing care to high-performance hospitals.纽约退伍军人健康管理局患者在私立部门进行冠状动脉血运重建的情况:通过将治疗导向高性能医院来改善治疗结果的机会。
Med Care. 2006 Jun;44(6):519-26. doi: 10.1097/01.mlr.0000215888.20004.5e.
8
Dual-System Use and Intermediate Health Outcomes among Veterans Enrolled in Medicare Advantage Plans.参加医疗保险优势计划的退伍军人的双系统使用情况及中期健康结果。
Health Serv Res. 2015 Dec;50(6):1868-90. doi: 10.1111/1475-6773.12303. Epub 2015 Apr 6.
9
Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria.医疗保险和退伍军人事务部在实施医院层面的适宜性使用标准报告后,经皮冠状动脉介入治疗编码适应证的趋势。
Circ Cardiovasc Qual Outcomes. 2021 Apr;14(4):e006887. doi: 10.1161/CIRCOUTCOMES.120.006887. Epub 2021 Mar 15.
10
Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者中的应用:来自退伍军人事务部临床评估、报告和跟踪计划的见解。
JACC Cardiovasc Interv. 2016 May 9;9(9):884-93. doi: 10.1016/j.jcin.2016.01.034. Epub 2016 Apr 13.

引用本文的文献

1
Payment Source Shift for Surgical Care Among Veterans Enrolled in Medicare Advantage Plans.参加医疗保险优势计划的退伍军人外科护理的支付来源转移
JAMA Health Forum. 2025 Jun 7;6(6):e250827. doi: 10.1001/jamahealthforum.2025.0827.
2
Characteristics and Benefit Design of Veteran Medicare Advantage Affinity Plans.退伍军人医疗保险优势亲和计划的特点与福利设计。
JAMA Health Forum. 2025 Mar 7;6(3):e250159. doi: 10.1001/jamahealthforum.2025.0159.
3
Veterans Health Administration benefit value has little effect on reliance.退伍军人健康管理局的福利价值对依赖程度影响甚微。

本文引用的文献

1
Medicare Advantage Checkup.医疗保险优势体检
N Engl J Med. 2018 Nov 29;379(22):2163-2172. doi: 10.1056/NEJMhpr1804089. Epub 2018 Nov 14.
2
Outcomes of Care for Ischemic Heart Disease and Chronic Heart Failure in the Veterans Health Administration.退伍军人事务部缺血性心脏病和慢性心力衰竭的治疗结果。
JAMA Cardiol. 2018 Jul 1;3(7):563-571. doi: 10.1001/jamacardio.2018.1115.
3
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.
Am J Manag Care. 2025 Feb 1;31(2):e56-e61. doi: 10.37765/ajmc.2025.89684.
4
Spending by the Veterans Health Administration for Medicare Advantage Dual Enrollees, 2011-2020.退伍军人健康管理局在2011年至2020年期间为医疗保险优势双重参保者的支出。
JAMA. 2024 Oct 2;332(16):1392-4. doi: 10.1001/jama.2024.18073.
5
Improvements and Gaps in Financial Risk Protection Among Veterans Following the Affordable Care Act.平价医疗法案实施后退伍军人的金融风险保护的改善和差距。
J Gen Intern Med. 2022 Feb;37(3):573-581. doi: 10.1007/s11606-021-06807-4. Epub 2021 May 6.
6
The U.S. Health Care System on the Eve of the Covid-19 Epidemic: A Summary of Recent Evidence on Its Impaired Performance.美国在新冠疫情爆发前夕的医疗体系:近期表现不佳的证据综述。
Int J Health Serv. 2020 Oct;50(4):408-414. doi: 10.1177/0020731420937631. Epub 2020 Jun 30.
2008-2016 年经皮冠状动脉介入治疗后抗血小板药物初治患者中血小板二磷酸腺苷 P2Y12 受体抑制剂的使用和依从性趋势。
JAMA Intern Med. 2018 Jul 1;178(7):943-950. doi: 10.1001/jamainternmed.2018.0783.
4
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries.医疗保险按服务收费与医疗保险优势计划受益人群中心血管手术应用的地域差异。
JAMA. 2013 Jul 10;310(2):155-62. doi: 10.1001/jama.2013.7837.
5
Duplicate federal payments for dual enrollees in Medicare Advantage plans and the Veterans Affairs health care system.医疗保险优势计划和退伍军人事务医疗保健系统中双重参保人的重复联邦支付。
JAMA. 2012 Jul 4;308(1):67-72. doi: 10.1001/jama.2012.7115.
6
Linking the National Cardiovascular Data Registry CathPCI Registry with Medicare claims data: validation of a longitudinal cohort of elderly patients undergoing cardiac catheterization.将国家心血管数据注册中心的心脏导管插入术注册数据与医疗保险理赔数据相链接:对接受心脏导管插入术的老年患者纵向队列的验证。
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):134-40. doi: 10.1161/CIRCOUTCOMES.111.963280.
7
Coronary revascularization trends in the United States, 2001-2008.美国 2001-2008 年冠状动脉血运重建趋势。
JAMA. 2011 May 4;305(17):1769-76. doi: 10.1001/jama.2011.551.
8
Medicare Advantage in the era of health reform: progress in leveling the playing field.医疗改革时代的医疗保险优势:在公平竞争环境方面取得的进展。
Issue Brief (Commonw Fund). 2011 Mar;5:1-14.
9
Relationship between clinical conditions and use of Veterans Affairs health care among Medicare-enrolled veterans.医疗保险参保退伍军人的临床状况与使用退伍军人事务部医疗保健之间的关系。
Health Serv Res. 2010 Jun;45(3):762-91. doi: 10.1111/j.1475-6773.2010.01107.x. Epub 2010 Apr 6.
10
A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.将埃利克斯豪泽共病测量法修改为一种使用行政数据的医院死亡点数系统。
Med Care. 2009 Jun;47(6):626-33. doi: 10.1097/MLR.0b013e31819432e5.